IMM — ImmuPharma Share News
0.000.00%
Holding(s) in Company
Attending JPMorgan Conference & Biotech Showcase
Corporate Update
Holding(s) in Company
Immupharma Attending Bio: EUROPE
Launch of Website; Corporate Update
Appointment of Independent Non-Executive Director
Holding(s) in Company
Exercise of Warrants
Holding(s) in Company
Interim Results
Holding(s) in Company
Notice of AGM
Final Results
Warrant Extension, Debt Conversion & Equity Issue
Extension of Warrants in Incanthera to 30 Sep 2025
IMM attending Bio-Europe Spring 17-19 March,Milan
ImmuPharma proves unique Mechanism of Action-P140
Holding(s) in Company